Surviving cancer is a victory, but the treatment itself can leave lasting wounds. Radiation therapy is one of the most effective cancer treatments available, but it does not stop affecting tissue after the treatment course ends. Late radiation injury, which can emerge months or years after therapy is complete, affects hundreds of thousands of cancer survivors. Hyperbaric oxygen therapy (HBOT) is one of the most evidence-backed interventions for these injuries, and for good reason: it targets the root cause of radiation damage rather than just managing symptoms. This is one of several HBOT for cancer treatment and side effects currently under clinical review.
How Radiation Damages Tissue Over Time
Radiation therapy works by damaging the DNA of rapidly dividing cancer cells. Unfortunately, it also affects the surrounding healthy tissue, particularly the small blood vessels (capillaries and arterioles) that supply it. This vascular damage does not manifest immediately. Over months and years following treatment, the damaged vessels become progressively obliterated through a process called endarteritis obliterans: the vessel walls thicken, blood flow decreases, and the tissue becomes chronically oxygen-deprived.
This creates a self-perpetuating cycle called the “three H” pathway: hypoxia (low oxygen), hypovascularity (few blood vessels), and hypocellularity (few cells). Oxygen-starved tissue cannot heal normally. Any trauma, surgery, or infection in a previously irradiated field heals poorly or not at all. Fibrosis accumulates. Eventually the tissue may break down entirely, resulting in wounds, fistulas, bone death, or severe organ dysfunction.
A 2023 Cochrane review of 18 RCTs with 1,071 patients found that HBOT was 39% more likely to achieve complete resolution or significant improvement of late radiation tissue injury compared to controls (RR 1.39, 95% CI 1.02-1.89).1
Types of Radiation Injury HBOT Is Used For
Radiation Cystitis
One of the most common and debilitating radiation injuries, radiation cystitis affects the bladder after pelvic radiation for prostate, cervical, rectal, or bladder cancers. Symptoms include urinary frequency, urgency, pain, and bleeding. HBOT has some of its strongest evidence in this area. The dedicated radiation cystitis and HBOT article covers the clinical evidence in detail, including response rates of 84-90% across multiple meta-analyses.
Radiation Proctitis
Radiation proctitis involves damage to the rectum and lower bowel after pelvic radiation. It causes bleeding, diarrhea, urgency, and in severe cases, fistulas or bowel obstruction. The Cochrane review found a relative risk of 1.72 for improvement or cure with HBOT (number needed to treat: 5).1
Osteoradionecrosis (Jaw Bone Death)
Head and neck cancer survivors who receive radiation to the jaw area are at risk for osteoradionecrosis (ORN), where the jawbone loses its blood supply and begins to die. Tooth extractions in irradiated jaw tissue carry particularly high risk. The Cochrane review found HBOT achieved mucosal coverage in ORN at RR 1.3 (95% CI 1.1-1.6, NNTB 5), and reduced ORN wound breakdown risk significantly (RR 4.2, 95% CI 1.1-16.8, NNTB 4).1
Soft Tissue Radiation Necrosis
Radiation can cause necrosis in soft tissue anywhere in a treatment field: breast tissue after breast cancer radiation, chest wall tissue, pelvic floor tissue, and more. HBOT is used to support healing when surgical debridement and reconstruction are needed in previously irradiated areas, improving the vascularity of the tissue bed before and after surgery. The Cochrane review found surgical flap survival was dramatically improved with HBOT (RR 8.7, 95% CI 2.7-27.5, NNTB 4).1
Radiation-Induced Brain and Spinal Cord Injury
Radiation necrosis of the brain or spinal cord is a serious complication of CNS radiation. HBOT has been used as an adjunct treatment in some cases, though the evidence base is smaller than for pelvic or jaw radiation injuries. Notably, the Cochrane review found no demonstrated benefit for neural tissue injury, so expectations should be calibrated accordingly.1
How Does HBOT Work for Radiation Damage?
HBOT’s mechanism in radiation injury is well understood. By dramatically increasing plasma oxygen levels (delivering oxygen at 2.0-2.5 ATA), HBOT reaches the chronically hypoxic tissue that radiation has starved of its blood supply. With repeated sessions, HBOT stimulates angiogenesis: the growth of new blood vessels into the ischemic tissue. This produces lasting improvement rather than just a temporary oxygen boost. Patients rebuild a new vascular network in their damaged tissue.
This is why response to HBOT for radiation injury tends to be durable. A large US registry study of 2,538 patients found symptom improvement or resolution rates of 76.7% to 92.6% depending on injury type, with osteoradionecrosis showing the highest improvement scores.3
What Does the Research Say?
Radiation tissue injury is one of the most evidence-backed applications for HBOT. The Undersea and Hyperbaric Medical Society (UHMS) formally endorses it as an approved indication, and the FDA has cleared HBOT for delayed radiation tissue injury. Medicare and most commercial insurers cover it when properly documented.
A 2025 systematic review of 17 studies with 640 head and neck cancer patients found positive outcomes in 14 of 17 studies (82%), with significant p-values in 11 studies.4 A 2025 review specifically on bowel and bladder radiation injury confirmed beneficial effect across 3 RCTs (273 patients) though heterogeneous trial designs prevented meta-analysis.5
What Does the HBOT Protocol Look Like?
Standard radiation injury protocols involve 30 to 40 sessions at 2.0 to 2.4 ATA, with each session running 90 minutes. Treatment is typically five days per week, making a full course six to eight weeks. For osteoradionecrosis being treated surgically, a combined protocol is used: typically 20 sessions before surgery and 10 sessions after. Improvement is gradual, and the angiogenic response continues for weeks to months after the final session. The session guide explains the logistics of treatment.
Insurance and Cost Considerations
Radiation injury is one of the best-covered HBOT indications. Medicare covers HBOT for delayed radiation tissue damage when certain criteria are met, including documentation of radiation history, adequate trial of conventional treatment, and treatment at an approved facility. Most commercial insurers follow Medicare’s coverage guidelines. Prior authorization is almost always required. The insurance coverage guide walks through how to navigate this process.
Who Is Not a Good Candidate
HBOT for radiation injury requires confirmation of no active malignancy in the treatment area. A clear oncology assessment is standard before starting treatment. Other general HBOT contraindications, including untreated pneumothorax, certain medications, and untreated ear or sinus conditions, also apply. Smoking significantly impairs the angiogenic response and most hyperbaric programs require cessation before starting treatment.
The Surgical Connection: HBOT Before and After Reconstruction
For cancer survivors who need reconstructive surgery in previously irradiated tissue, HBOT has a dual role: preparing the tissue bed pre-operatively and supporting healing post-operatively. Irradiated tissue that receives HBOT prior to surgery develops improved vascularity, reducing the risk of wound breakdown and flap failure. The Cochrane review’s finding of RR 8.7 for surgical flap survival with HBOT is among the most compelling numbers in the evidence base.1
Long-Term Follow-Up After Radiation Injury HBOT
Most patients who respond to HBOT for radiation injury maintain improvements at 12 to 24 month follow-up. Radiation damage is a progressive underlying condition, and some patients experience recurrence of symptoms over time, particularly if new stress is applied to the irradiated tissue. Understanding that HBOT provides a meaningful improvement window rather than a guaranteed permanent cure sets appropriate expectations and supports decisions about maintenance or repeat treatment if symptoms recur.
Frequently Asked Questions
How long after radiation therapy can HBOT still help?
HBOT can help even when radiation injury develops years or decades after treatment. The angiogenic mechanism does not have a time limit. Studies include patients with osteoradionecrosis or proctitis that developed 10 or more years after radiation.
Can HBOT prevent radiation injury before it fully develops?
Prophylactic HBOT is well-established for dental procedures in previously irradiated jaw tissue, where it significantly reduces the risk of ORN. For other applications, prophylactic use is less standard, but some centers use pre-surgical HBOT to improve the vascularity of tissue in irradiated fields before reconstruction.
What if my radiation injury does not respond to HBOT?
Non-response or partial response does occur. Factors that reduce HBOT efficacy include very advanced tissue death, concurrent active infection, smoking, and active cancer. If HBOT fails to produce adequate response, surgical reconstruction may be needed.
Does smoking affect HBOT outcomes for radiation injury?
Yes, significantly. Smoking causes vasoconstriction and impairs angiogenesis, directly counteracting HBOT’s primary mechanism. Most hyperbaric programs strongly recommend smoking cessation before starting a course of HBOT for radiation damage.
References
- Lin Z, Bennett MH, Hawkins G, Azzopardi C, Feldmeier J, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2023;8:CD005005. DOI: 10.1002/14651858.CD005005.pub5. PMID: 37585677.
- Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries. Undersea Hyperb Med. 2002;29(1):4-30. PMID: 12507182.
- Niezgoda JA, Serena T, Carter MJ. Outcomes of Radiation Injuries Using Hyperbaric Oxygen Therapy. Adv Skin Wound Care. 2016;29(1):12-19. DOI: 10.1097/01.ASW.0000473679.29537.c0. PMID: 26650092.
- El Hadji S, Teguh D, Ridderikhof M. Hyperbaric oxygen therapy for late radiation tissue toxicity injury after head and neck cancer. Radiat Oncol. 2025;20:54. DOI: 10.1186/s13014-025-02680-1. PMID: 41044659.
- Eckert KA, Fife CE, Carter MJ. Systematic Review of Hyperbaric Oxygen for Late Radiation Tissue Injury (Bowel, Bladder). Undersea Hyperb Med. 2025. DOI: 10.22462/754. PMID: 41223393.
- Craighead PS, et al. Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol. 2011;18(5):e264-72. DOI: 10.3747/CO.V18I5.767. PMID: 21980249.
- Spruijt NE, van den Berg R. The effect of hyperbaric oxygen treatment on late radiation tissue injury after breast cancer. Diving Hyperb Med. 2020;50(3):206-213. DOI: 10.28920/dhm50.3.206-213. PMID: 32957121.
- Andren J, Bennett MH. An observational trial to establish the effect of hyperbaric oxygen treatment on pelvic late radiation tissue injury. Diving Hyperb Med. 2020;50(3):250-255. DOI: 10.28920/dhm50.3.250-255. PMID: 32957127.
- Borab ZM, et al. Systematic review of hyperbaric oxygen therapy for the treatment of radiation-induced skin necrosis. J Plast Reconstr Aesthet Surg. 2017;70(4):529-538. DOI: 10.1016/j.bjps.2016.11.024. PMID: 28081957.
- Tahir AM, et al. Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia’s largest study. Asia Pac J Clin Oncol. 2015;11(1):68-77. DOI: 10.1111/ajco.12289. PMID: 25382755.
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
